Funder
ministry of education and science of the republic of kazakhstan
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Clinical Biochemistry,Biochemistry,Analytical Chemistry
Reference23 articles.
1. Asmous VC (1943) Karelin (1801–1872) and Kirilov (1821–1842) explorers of Siberia and Middle Asia. J Arnold Arboretum 24: 107–117. https://www.jstor.org/stable/43781073
2. Abderrazak A, Couchie D, Mahmood DFD, Elhage R, Vindis C, Laffargue M, Mateo V, Buchele B, Ayaly MR, ElGaafary M, Syrovets T, Slimane M-N, Friguet B, Fulop T, Simmet T, El Hadri K, Rouis M (2015) Anti-Inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor Arglabin in ApoE2.Ki mice fed a high-fat diet. Circulation 131:1061–1070. https://doi.org/10.1161/circulationaha.114.013730
3. Abderrazak A, El Hadri K, Bosc E, Blondeau B, Slimane M-N, Buchele B, Simmet T, Couchie D, Rouis M (2016) Inhibition of the inflammasome NLRP3 by Arglabin attenuates inflammation, protects pancreatic β-cells from apoptosis, and prevents Type 2 diabetes mellitus development in ApoE2Ki mice on a chronic high-fat diet. J Pharmacol Exp Ther 357:487–494. https://doi.org/10.1124/jpet.116.232934
4. Adekenov S, Zhumakayeva A, Perminov V, Bekmanov B, Rakhimov K (2020) Neoadjuvent therapy with drug Arglabin for breast cancer with expression of H-Ras oncoproteins. Asian Pac J Cancer Prev 21:3441–3447. https://doi.org/10.31557/apjcp.2020.21.11.3441
5. Adekenov SM (2008) Method for producing radio-sensitizing agent from Artemisia glabella, Russian Patent EA9712